021-51111890
购物车（）
sales@molnova.cn
B2
CAS No. 115687-05-3
B2 ( CPNQ; Linazolamide intermediate B impurity 2; 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline )
产品货号. M27605 CAS No. 115687-05-3
B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1256 | 有现货 |
|
| 10MG | ￥2001 | 有现货 |
|
| 25MG | ￥3386 | 有现货 |
|
| 50MG | ￥4828 | 有现货 |
|
| 100MG | ￥6990 | 有现货 |
|
| 500MG | ￥13932 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称B2
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.
-
产品描述B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.
-
同义词CPNQ; Linazolamide intermediate B impurity 2; 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline
-
通路Others
-
靶点Other Targets
-
受体GABAB
-
研究领域——
-
适应症——
化学信息
-
CAS Number115687-05-3
-
分子量396.8
-
分子式C20H17ClN4O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[O-][N+](=O)c1ccc(N2CCN(CC2)C(=O)c2ccc(Cl)cc2)c2cccnc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Q Gillani, et al. CGP 35348, GABA B receptor antagonist, has a potential to improve neuromuscular coordination and spatial learning in albino mouse following neonatal brain damage. Biomed Res Int.?2014;2014:295215.
产品手册
关联产品
-
Sodium succinate
Sodium succinate is the sodium salt form of succinate which is an important metabolite at the cross-road of several metabolic pathways and involved in the formation and elimination of reactive oxygen species.
-
Delphinidin-3-O-gluc...
Delphinidin-3-O-glucoside chloride has antioxidant activity.
-
Myricetin 3-O-beta-D...
Myricetin 3-O-glucoside is a flavonol extracted from Tibouchina paratropica.
